| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Hematopathology Section, Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, Maryland 20892
CDKN2 (p16INK4A/MTS1) and p15INK4B/MTS2 have been shown recently to be potent inhibitors of the cyclin D/cyclin-dependent kinase 4 complex. Both genes are candidates for the putative tumor suppressor gene located at chromosome 9p21. We examined a series of 14 hematopoietic cell lines and 117 primary lymphoid tumors for deletion and mutation of these genes. The primary tumors included 65 T-cell malignancies and 52 B-cell malignancies. The cell line study revealed 4 of 4 T-ALL lines to have homozygous deletions of CDKN2. Two of the 4 lines also showed homozygous deletions of MTS2, while the remaining 2 lines retained both MTS2 alleles. In the primary tumors, homozygous deletions of both CDKN2 and MTS2 were found in 35% of the T-ALL/lymphoblastic lymphoma (8 of 23). Homozygous deletions of both genes also occurred in 1 of 3 precursor B-ALLs. PCR-single strand conformational polymorphism analysis of CDKN2 exons 2 and 3 and MTS2 exon 2 failed to demonstrate mutations in either CDKN2 or MTS2 in any of the T- or B-cell malignancies, with two possible exceptions. These results are consistent with a role for CDKN2 and/or MTS2 in the pathogenesis of some lymphoid leukemia/lymphomas, particularly in T-ALL/lymphoblastic lymphoma.
1 To whom requests for reprints should be addressed, at Hematopathology Section Laboratory of Pathology, Building 10, Room 2N110, National Cancer Institute, NIH, Bethesda, MD 20892.
Received 1/10/95. Accepted 2/16/95.
This article has been cited by other articles:
|
|
 |
|
  F. A. Mallette, M.-F. Gaumont-Leclerc, G. Huot, and G. Ferbeyre Myc Down-regulation as a Mechanism to Activate the Rb Pathway in STAT5A-induced Senescence J. Biol. Chem., November 30, 2007; 282(48): 34938 - 34944. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Passioura, A. Dolnikov, S. Shen, and G. Symonds N-Ras-Induced Growth Suppression of Myeloid Cells Is Mediated by IRF-1 Cancer Res., February 1, 2005; 65(3): 797 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Vaque, J. Navascues, Y. Shiio, M. Laiho, N. Ajenjo, I. Mauleon, D. Matallanas, P. Crespo, and J. Leon Myc Antagonizes Ras-mediated Growth Arrest in Leukemia Cells through the Inhibition of the Ras-ERK-p21Cip1 Pathway J. Biol. Chem., January 14, 2005; 280(2): 1112 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sanchez-Aguilera, J. Delgado, F. I. Camacho, M. Sanchez-Beato, L. Sanchez, C. Montalban, M. F. Fresno, C. Martin, M. A. Piris, and J. F. Garcia Silencing of the p18INK4c gene by promoter hypermethylation in Reed-Sternberg cells in Hodgkin lymphomas Blood, March 15, 2004; 103(6): 2351 - 2357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Garcia, B. Martinez-Delgado, A. Cebrian, A. Martinez, J. Benitez, and C. Rivas Different Incidence and Pattern of p15INK4b and p16INK4a Promoter Region Hypermethylation in Hodgkin's and CD30-Positive Non-Hodgkin's Lymphomas Am. J. Pathol., September 1, 2002; 161(3): 1007 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Lewis, W. Chinswangwatanakul, B. Zheng, S. B. Marley, D. X. Nguyen, N. C. P. Cross, L. Banerji, J. Glassford, N. S. B. Thomas, J. M. Goldman, et al. The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells Blood, May 1, 2001; 97(9): 2604 - 2610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Cachia, J. O. Indsto, K. M. McLaren, G. J. Mann, and M. J. Arends CDKN2A Mutation and Deletion Status in Thin and Thick Primary Melanoma Clin. Cancer Res., September 1, 2000; 6(9): 3511 - 3515. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. BERNHARD, M. J. AUSSERLECHNER, M. TONKO, M. LÖFFLER, B. L. HARTMANN, A. CSORDAS, and R. KOFLER Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts FASEB J, November 1, 1999; 13(14): 1991 - 2001. [Abstract] [Full Text]
|
|
|
|
|
|
A. S. Baur, P. Shaw, N. Burri, F. Delacretaz, F. T. Bosman, and P. Chaubert Frequent Methylation Silencing of p15INK4b (MTS2) and p16INK4a (MTS1) in B-Cell and T-Cell Lymphomas Blood, September 1, 1999; 94(5): 1773 - 1781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S.J. Elenitoba-Johnson, R. D. Gascoyne, M. S. Lim, M. Chhanabai, E. S. Jaffe, and M. Raffeld Homozygous Deletions at Chromosome 9p21 Involving p16 and p15 Are Associated With Histologic Progression in Follicle Center Lymphoma Blood, June 15, 1998; 91(12): 4677 - 4685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pinyol, F. Cobo, S. Bea, P. Jares, I. Nayach, P. L. Fernandez, E. Montserrat, A. Cardesa, and E. Campo p16INK4a Gene Inactivation by Deletions, Mutations, and Hypermethylation Is Associated With Transformed and Aggressive Variants of Non-Hodgkin's Lymphomas Blood, April 15, 1998; 91(8): 2977 - 2984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Foster, D. J. Wong, M. T. Barrett, and D. A. Galloway Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island Methylation Mol. Cell. Biol., April 1, 1998; 18(4): 1793 - 1801. [Abstract] [Full Text]
|
|
|
|
|
|
U. R. Kees, P. R. Burton, C. Lu, and D. L. Baker Homozygous Deletion of the p16/MTS1 Gene in Pediatric Acute Lymphoblastic Leukemia Is Associated With Unfavorable Clinical Outcome Blood, June 1, 1997; 89(11): 4161 - 4166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pinyol, L. Hernandez, M. Cazorla, M. Balbin, P. Jares, P. L. Fernandez, E. Montserrat, A. Cardesa, C. Lopez-Otin, and E. Campo Deletions and Loss of Expression of P16INK4a and P21Waf1 Genes Are Associated With Aggressive Variants of Mantle Cell Lymphomas Blood, January 1, 1997; 89(1): 272 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gray-Bablin, J. Zalvide, M. P. Fox, C. J. Knickerbocker, J. A. DeCaprio, and K. Keyomarsi Cyclin E, a redundant cyclin in breast cancer PNAS, December 24, 1996; 93(26): 15215 - 15220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Ausserlechner, P. Obexer, G. J. Wiegers, B. L. Hartmann, S. Geley, and R. Kofler The Cell Cycle Inhibitor p16INK4A Sensitizes Lymphoblastic Leukemia Cells to Apoptosis by Physiologic Glucocorticoid Levels J. Biol. Chem., March 30, 2001; 276(14): 10984 - 10989. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
